SEC
SlamSEC
Search
Browse
Earnings
ANAPTYSBIO, INC
Nasdaq:
ANAB
Pharmaceutical Preparations
·
SAN DIEGO, CA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
ANAPTYSBIO, INC — SlamSEC
Revenue
$17.2M
+66.8% YoY
FY 2025
Adj. EBITDA
-$163.8M
-954.5% margin
FY 2025
Net Income
-$163.6M
-953.7% margin
FY 2025
EPS (Diluted)
-$6.08
FY 2025
Stock Price
$61.61
+11.2%
2026-03-10
52W Range
$15.32 – $63.47
P/E Ratio
-10.1x
Market Cap
$1.8B
Cash
$123.1M
FY 2025
Total Debt
$1.4M
FY 2020
Net Cash
$121.7M
FY 2020
Enterprise Value
$1.6B
Debt / EBITDA
0.7x
FY 2025
EV / EBITDA
-10.1x
Employees
—